David Lubner - Jun 2, 2022 Form 4 Insider Report for POINT Biopharma Global Inc. (PNT)

Role
Director
Signature
/s/ William L. Demers, by Power of Attorney for David Charles Lubner
Stock symbol
PNT
Transactions as of
Jun 2, 2022
Transactions value $
$0
Form type
4
Date filed
6/6/2022, 04:04 PM
Previous filing
Feb 9, 2022
Next filing
Jun 6, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PNT Stock Option (Right to Buy) Award $0 +25.6K $0.00 25.6K Jun 2, 2022 Common Stock 25.6K $8.31 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest 100% on the first anniversary of the grant date.